A novel brief treatment for methamphetamine use disorders in South Africa: a randomised feasibility trial.

Journal: Addiction science & clinical practice

Volume: 16

Issue: 1

Year of Publication: 2021

Affiliated Institutions:  Alan J. Flisher Centre for Public Mental Health, Department of Psychiatry & Mental Health, University of Cape Town, Sawkins Rd., Cape Town, , South Africa. Katherine.sorsdahl@uct.ac.za. Department of Psychiatry & Mental Health, University of Cape Town, Cape Town, South Africa. Department of Psychology, Stellenbosch University, Stellenbosch, South Africa. Alan J. Flisher Centre for Public Mental Health, Department of Psychiatry & Mental Health, University of Cape Town, Sawkins Rd., Cape Town, , South Africa. Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA. Professional Data Analysts, Minneapolis, United States. Department of Psychiatry & Behavioural Neuroscience, University of Chicago, Chicago, United States.

Abstract summary 

Effective brief treatments for methamphetamine use disorders (MAUD) are urgently needed to complement longer more intensive treatments in low and middle income countries, including South Africa. To address this gap, the purpose of this randomised feasibility trial was to determine the feasibility of delivering a six-session blended imaginal desensitisation, plus motivational interviewing (IDMI) intervention for adults with a MAUD.We enrolled 60 adults with a MAUD and randomly assigned them 1:1 to the IDMI intervention delivered by clinical psychologists and a control group who we referred to usual care. Feasibility measures, such as rates of recruitment, consent to participate in the trial and retention, were calculated. Follow-up interviews were conducted at 6 weeks and 3 months post-enrollment.Over 9 months, 278 potential particiants initiated contact. Following initial screening 78 (28%) met inclusion criteria, and 60 (77%) were randomised. Thirteen of the 30 participants assigned to the treatment group completed the intervention. Both psychologists were highly adherent to the intervention, obtaining a fidelity rating of 91%. In total, 39 (65%) participants completed the 6-week follow-up and 40 (67%) completed the 3-month follow-up. The intervention shows potential effectiveness in the intention-to-treat analysis where frequency of methamphetamine use was significantly lower in the treatment than in the control group at both the 6 week and 3-month endpoints. No adverse outcomes were reported.This feasibility trial suggests that the locally adapted IDMI intervention is an acceptable and safe intervention as a brief treatment for MAUD in South Africa. Modifications to the study design should be considered in a fully powered, definitive controlled trial to assess this potentially effective intervention. Trial registration The trial is registered with the Pan African Clinical Trials Registry (Trial ID: PACTR201310000589295).

Authors & Co-authors:  Sorsdahl K K Stein D J DJ Pasche S S Jacobs Y Y Kader R R Odlaug B B Richter S S Myers B B Grant J E JE

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England) 2015;386(1001010010):2287–2323. doi: 10.1016/S0140-6736(15)00128-2.
Authors :  9
Identifiers
Doi : 3
SSN : 1940-0640
Study Population
Male,Female
Mesh Terms
Adult
Other Terms
Brief treatment;Feasibility trial;South Africa;Substance use
Study Design
Case Control Trial,Cross Sectional Study
Study Approach
Country of Study
South Africa
Publication Country
England